Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProLact is a Bulgarian biotechnology company specializing in the development and production of advanced probiotic products and functional foods. The company utilizes a unique natural micro-encapsulation technology, originally developed for space programs, which ensures the survival of beneficial bacteria through the digestive tract. Their product portfolio includes a wide range of probiotic supplements derived from goat and cow milk, targeted at improving gut health, immunity, and overall wellness. ProLact operates its own manufacturing facility and focuses on high-concentration, multi-strain formulations that are scientifically backed for efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProLact.